Clinical Trials Browser

Phase 3 × Has results × durvalumab × Clear all

Carcinoma, Hepatocellular

Carcinoma, Transitional Cell

Biliary Tract Neoplasms

Non Small Cell Lung Cancer NSCLC

Urinary Bladder Neoplasms

Non Small Cell Lung Carcinoma NSCLC

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Urothelial Cancer

Endometrial Neoplasms

Carcinoma, Lung Neoplasms, Small Cell Lung Carcinoma

Carcinoma, Carcinoma, Non-Small-Cell Lung

Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma Extensive Disease

Small Cell Lung Carcinoma Extensive Disease

Carcinoma, Non-Small-Cell Lung

Locally Advanced or Metastatic EGFR T790M+ NSCLC

Carcinoma, Non-Small-Cell Lung

Non - Small Cell Lung Cancer NSCLC

Locally Advanced Cervical Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Diabetes Mellitus, Insulin-Dependent, 12

Squamous Cell Carcinoma of Head and Neck

Head and Neck Neoplasms, Recurrence

Clinical Trials

HIMALAYA

IMAGINE

TOPAZ-1

POSEIDON

NIAGARA

Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL)

MYSTIC

PACIFIC-5

Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer

DUO-E

ADRIATIC

Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer

CASPIAN

CheckMate73L

LUMINANCE

CANTABRICO

Durvalumab Plus Chemotherapy in ES-SCLC (Oriental)

A Study to Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (cCRT) in Participants With Stage III Unresectable Non-Small Cell Lung Cancer

CAURAL

MERMAID-1

ARCTIC

CALLA

MERMAID-2

PACIFIC

STRONG

KESTREL

EAGLE